DermTech
Pre-clinicalThe DermTech Melanoma Test® is a non-invasive genomic test utilizing DermTech Smart Stickers® to assess equivocal melanocytic lesions meeting one or more of the ABCDE criteria. It detects genomic markers associated with melanoma to distinguish benign from higher risk lesions.
Founded
1995
Focus
Diagnostics
About
The DermTech Melanoma Test® is a non-invasive genomic test utilizing DermTech Smart Stickers® to assess equivocal melanocytic lesions meeting one or more of the ABCDE criteria. It detects genomic markers associated with melanoma to distinguish benign from higher risk lesions.
Funding History
4Total raised: $120M
IPO$60MUndisclosedJul 15, 2018
Series C$30MUndisclosedDec 15, 2017
Series B$20MUndisclosedJun 15, 2016
Series A$10MUndisclosedJan 15, 2015
Company Info
TypePrivate
Founded1995
LocationLa Jolla, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile